Cargando…

Biological dosimetric impact of dose-delivery time for hypoxic tumour with modified microdosimetric kinetic model

BACKGROUND: An improved microdosimetric kinetic model (MKM) can address radiobiological effects with prolonged delivery times. However, these do not consider the effects of oxygen. The current study aimed to evaluate the biological dosimetric effects associated with the dose delivery time in hypoxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawahara, Daisuke, Nagata, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547428/
https://www.ncbi.nlm.nih.gov/pubmed/37795224
http://dx.doi.org/10.5603/RPOR.a2023.0062
_version_ 1785115058092638208
author Kawahara, Daisuke
Nagata, Yasushi
author_facet Kawahara, Daisuke
Nagata, Yasushi
author_sort Kawahara, Daisuke
collection PubMed
description BACKGROUND: An improved microdosimetric kinetic model (MKM) can address radiobiological effects with prolonged delivery times. However, these do not consider the effects of oxygen. The current study aimed to evaluate the biological dosimetric effects associated with the dose delivery time in hypoxic tumours with improved MKM for photon radiation therapy. MATERIALS AND METHODS: Cell survival was measured under anoxic, hypoxic, and oxic conditions using the Monte Carlo code PHITS. The effect of the dose rate of 0.5–24 Gy/min for the biological dose (D(bio)) was estimated using the microdosimetric kinetic model. The dose per fraction and pressure of O(2) (pO(2)) in the tumour varied from 2 to 20 Gy and from 0.01 to 5.0% pO(2), respectively. RESULTS: The ratio of the D(bio) at 1.0–24 Gy/min to that at 0.5 Gy/min (R(DR)) was higher at higher doses. The maximum R(DR) was 1.09 at 1.0 Gy/min, 1.12 at 12 Gy/min, and 1.13 at 24 Gy/min. The ratio of the D(bio) at 0.01–2.0% of pO(2) to that at 5.0% of pO(2) (R(oxy)) was within 0.1 for 2–20 Gy of physical dose. The maximum R(oxy) was 0.42 at 0.01% pO(2), 0.76 at 0.4% pO(2), 0.89 at 1% pO(2), and 0.96 at 2% pO(2). CONCLUSION: Our proposed model can estimate the cell killing and biological dose under hypoxia in a clinical and realistic patient. A shorter dose-delivery time with a higher oxygen distribution increased the radiobiological effect. It was more effective at higher doses per fraction than at lower doses.
format Online
Article
Text
id pubmed-10547428
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Via Medica
record_format MEDLINE/PubMed
spelling pubmed-105474282023-10-04 Biological dosimetric impact of dose-delivery time for hypoxic tumour with modified microdosimetric kinetic model Kawahara, Daisuke Nagata, Yasushi Rep Pract Oncol Radiother Research Paper BACKGROUND: An improved microdosimetric kinetic model (MKM) can address radiobiological effects with prolonged delivery times. However, these do not consider the effects of oxygen. The current study aimed to evaluate the biological dosimetric effects associated with the dose delivery time in hypoxic tumours with improved MKM for photon radiation therapy. MATERIALS AND METHODS: Cell survival was measured under anoxic, hypoxic, and oxic conditions using the Monte Carlo code PHITS. The effect of the dose rate of 0.5–24 Gy/min for the biological dose (D(bio)) was estimated using the microdosimetric kinetic model. The dose per fraction and pressure of O(2) (pO(2)) in the tumour varied from 2 to 20 Gy and from 0.01 to 5.0% pO(2), respectively. RESULTS: The ratio of the D(bio) at 1.0–24 Gy/min to that at 0.5 Gy/min (R(DR)) was higher at higher doses. The maximum R(DR) was 1.09 at 1.0 Gy/min, 1.12 at 12 Gy/min, and 1.13 at 24 Gy/min. The ratio of the D(bio) at 0.01–2.0% of pO(2) to that at 5.0% of pO(2) (R(oxy)) was within 0.1 for 2–20 Gy of physical dose. The maximum R(oxy) was 0.42 at 0.01% pO(2), 0.76 at 0.4% pO(2), 0.89 at 1% pO(2), and 0.96 at 2% pO(2). CONCLUSION: Our proposed model can estimate the cell killing and biological dose under hypoxia in a clinical and realistic patient. A shorter dose-delivery time with a higher oxygen distribution increased the radiobiological effect. It was more effective at higher doses per fraction than at lower doses. Via Medica 2023-08-28 /pmc/articles/PMC10547428/ /pubmed/37795224 http://dx.doi.org/10.5603/RPOR.a2023.0062 Text en © 2023 Greater Poland Cancer Centre https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially
spellingShingle Research Paper
Kawahara, Daisuke
Nagata, Yasushi
Biological dosimetric impact of dose-delivery time for hypoxic tumour with modified microdosimetric kinetic model
title Biological dosimetric impact of dose-delivery time for hypoxic tumour with modified microdosimetric kinetic model
title_full Biological dosimetric impact of dose-delivery time for hypoxic tumour with modified microdosimetric kinetic model
title_fullStr Biological dosimetric impact of dose-delivery time for hypoxic tumour with modified microdosimetric kinetic model
title_full_unstemmed Biological dosimetric impact of dose-delivery time for hypoxic tumour with modified microdosimetric kinetic model
title_short Biological dosimetric impact of dose-delivery time for hypoxic tumour with modified microdosimetric kinetic model
title_sort biological dosimetric impact of dose-delivery time for hypoxic tumour with modified microdosimetric kinetic model
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547428/
https://www.ncbi.nlm.nih.gov/pubmed/37795224
http://dx.doi.org/10.5603/RPOR.a2023.0062
work_keys_str_mv AT kawaharadaisuke biologicaldosimetricimpactofdosedeliverytimeforhypoxictumourwithmodifiedmicrodosimetrickineticmodel
AT nagatayasushi biologicaldosimetricimpactofdosedeliverytimeforhypoxictumourwithmodifiedmicrodosimetrickineticmodel